VelosBio to be Acquired by Merck…
RESEARCH TRIANGLE PARK, NC, Nov. 5, 2020 — Pappas Capital, a leading venture capital firm focused on advancing life sciences, today announced that its portfolio company, VelosBio Inc. (“VelosBio” or the...
Read More
Investor Login
Toggle navigation
Home
About
About Us
News & Events
For Entrepreneurs
Contact Us
Team
Portfolio
Ventures
Specialized Funds
About
Chiesi Ventures Fund
Specialized Holdings
Translational Medicine
About
Wake Forest Technology Development Program
Home
About
Team
Portfolio
News & Events
Contact
Ventures
Specialized Funds
Translational Medicine
© 2021 Pappas Capital, LLC. ALL RIGHTS RESERVED.
Investor Login
Investor Login
© 2018 Pappas Capital, LLC. ALL RIGHTS RESERVED.
